Document:

EX-4.2

 Exhibit 4.2 

EXECUTION VERSION 

SUPPLEMENTAL INDENTURE NO. 2 

SUPPLEMENTAL INDENTURE NO. 2 (this “Supplemental Indenture”) dated as of April 18, 2017 among Affinion Investments, LLC,
a Delaware limited liability company (the “Issuer”), Affinion Investments II, LLC, a Delaware limited liability company (the “Guarantor”), and Wells Fargo Bank, National Association, a national banking association,
as trustee (the “Trustee”) under the Indenture (as defined below). 
 W I T N E S S E T H : 

WHEREAS, the Issuer and the Guarantor have heretofore executed and delivered to the Trustee an indenture (as amended, supplemented or
otherwise modified, the “Indenture”) dated as of December 12, 2013, providing for the issuance of the Issuer’s 13.50% Senior Subordinated Notes due 2018 (the “Notes”); 

WHEREAS, pursuant to Section 9.02 of the Indenture, the Issuer, the Guarantor and the Trustee are authorized to execute and deliver this
Supplemental Indenture with the written consent (the “Consents”) of Holders of at least a majority in principal amount of the Notes then outstanding voting as a single class and calculated in accordance with the Indenture (the
“Required Consents”); 
 WHEREAS, the Issuer has offered to exchange (the “Exchange Offer”) any and all of
the outstanding Notes upon the terms and subject to the conditions set forth in the Offering Memorandum and Consent Solicitation Statement dated April 3, 2017 (as it may be amended or supplemented from time to time, the “Offering
Memorandum”); 
 WHEREAS, in connection with the Exchange Offer, the Issuer has solicited consents from Holders to the amendments
contained herein (collectively, the “Proposed Amendments”) and the execution of this Supplemental Indenture; 
 WHEREAS,
the Issuer has received Consents to the Proposed Amendments and the execution of this Supplemental Indenture from Holders of at least a majority in principal amount of the Notes then outstanding voting as a single class and calculated in accordance
with the Indenture, and accordingly the Issuer has received the Required Consents; 
 WHEREAS, this Supplemental Indenture has not resulted
in a material modification of the Notes for Foreign Account Tax Compliance Act purposes; and 
 WHEREAS, pursuant to Section 9.06, the
Trustee is authorized to execute and deliver this Supplemental Indenture. 

  
 1 

 NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration,
the receipt of which is hereby acknowledged, (i) the Issuer, (ii) the Guarantor and (iii) the Trustee, strictly on the basis of Holder consent, authorization and direction, as evidenced by the Required Consents, mutually covenant and
agree for the equal and ratable benefit of the Holders of the Notes as follows: 
 1. Effectiveness of Supplemental Indenture. This Supplemental
Indenture shall become effective as of the date hereof; provided that the amendments to the Indenture set forth in Section 2 hereof shall not become operative until (i) the Issuer pays the Total Consideration or Exchange
Consideration (each as defined in the Offering Memorandum), as applicable, in each case to Holders who have validly tendered (and not withdrawn) Notes (along with the related consents) in accordance with the terms of the Offering Memorandum and
(ii) the Issuer informs the Trustee in writing that the payments in clause (i) have been made (the “Amendment Effective Time”). If the Amendment Effective Time does not occur (a) on or prior to the Settlement Date (as
defined in the Offering Memorandum) for the Exchange Offer or (b) prior to the Termination Date (as defined in the Support Agreement, dated as of March 31, 2017, by and among the Issuer, Affinion Group Holdings, Inc., Affinion Group, Inc.
and certain holders of Notes parties thereto, as amended from time to time), or if the Exchange Offer is not otherwise consummated for any reason upon the terms and conditions described in the Offering Memorandum, then the terms of this Supplemental
Indenture shall be null and void and the Indenture and Notes shall continue in full force and effect without any modification or amendment hereby. 
 2.
Amendments to Indenture. The Indenture is hereby amended by: 
 (a) adding to Section 1.01 of the Indenture: 

“Amendment Effective Time” shall mean the “Amendment Effective Time” as defined in Supplemental Indenture No. 2
dated as of April 18, 2017, among the Issuer, the Guarantor and the Trustee. 
 (b) (i) deleting the words “40 days but not more
than 60 days before a redemption date” in the second sentence of Section 3.03 of the Indenture and replacing such deletion with “five Business Days but not more than 60 calendar days before a redemption date” and
(ii) deleting the words “30 days but not more than 60 days before a redemption date” in the first sentence of Section 3.05(a) of the Indenture and replacing such deletion with “three Business Days but not more than 60
calendar days before a redemption date.” 
 3. Amendments to Notes. The Notes are hereby amended by (i) deleting the words “30 nor
more than 60 days’ prior notice” and replacing such deletion with “three Business Days nor more than 60 calendar days’ prior notice” in each of the first sentence in the second paragraph and the first sentence in the third
paragraph of Paragraph 5 of the Securities captioned “Optional Redemption” and (ii) deleting the words “30 days but not more than 60 days before the redemption date” and replacing such deletion with “three Business Days
but not more than 60 calendar days before the redemption date” in the first sentence of Paragraph 6 of the Notes captioned “Notice of Redemption.” 

4. Defined Terms. As used in this Supplemental Indenture, terms defined in the Indenture or in the preamble or recital hereto are used herein as
therein defined. The words “herein,” “hereof” and “hereby” and other words of similar import used in this Supplemental Indenture refer to this Supplemental Indenture as a whole and not to any particular section hereof.

 5. Ratification of Indenture; Supplemental Indenture Part of Indenture. Except as expressly amended hereby, the Indenture is in all respects
ratified and confirmed and all the terms, 

  
 2 

 
conditions and provisions thereof shall remain in full force and effect. This Supplemental Indenture shall form a part of the Indenture for all purposes, and every Holder of Notes heretofore or
hereafter authenticated and delivered shall be bound hereby. 
 6. Governing Law. THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN
ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
 7. Trustee Makes No Representation. The Trustee shall not be responsible in any manner
whatsoever for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer. Furthermore, the Trustee makes no representation as to the validity or sufficiency of this Supplemental Indenture. The Trustee enters
into this Supplemental Indenture strictly to give effect to the commercial agreement reached between the Issuer and the Holders, and on the basis of Holder consent, authorization and direction, as evidenced by the Requisite Consents. The Issuer
hereby reaffirms its obligation under the Indenture to indemnify and hold harmless the Trustee as required under Article 7 of the Indenture, including under Section 7.07 of the Indenture, and in particular (but not limited to) against losses,
liabilities, claims, damages or expenses (including the reasonable fees and expenses of its counsel) arising out of or in connection with its execution and performance of this Supplemental Indenture. This indemnity shall survive the final payment in
full of the Notes and the resignation or removal of the Trustee solely to the extent expressly provided in Section 8.01(c) or Section 7.08 of the Indenture, as applicable. 

8. Counterparts. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them
together represent the same agreement. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties
hereto and may be used in lieu of the original Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. 

9. Effect of Headings. The Section headings herein are for convenience only and shall not affect the construction thereof. 

10. Successors and Assigns. All covenants and agreements in this Supplemental Indenture by the Issuer shall bind its successors and assigns, whether so
expressed or not. 
 11. Severability. If and to the extent that any provision in this Supplemental Indenture shall be held invalid, illegal or
unenforceable, or any proposed amendment to the Indenture shall be held not to have been properly approved by all necessary Holders as required under the Indenture, the validity, legality, enforceability and approval of the remaining provisions
shall not in any way be affected or impaired thereby, to the extent permitted by applicable law. 
 [Signature Pages to Follow] 

  
 3 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed on the date first written above. 
  

					
	AFFINION INVESTMENTS, LLC
		
	By:	 	Affinion Group, Inc., its Non-Economic
		 	Managing Member
		
	By:	 	 /s/ Gregory S. Miller

		 	Name:	 	Gregory S. Miller
		 	Title:	 	Executive Vice President and Chief
		 		 	Financial Officer
	
	AFFINION INVESTMENTS II, LLC
		
	By:	 	 /s/ Gregory S. Miller

		 	Name:	 	Gregory S. Miller
		 	Title:	 	Executive Vice President and Chief
		 		 	Financial Officer

  
 [Signature Page to
Investments Supplemental Indenture No. 2] 

 
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee
		
	By:	 	 /s/ Maddy Hughes

		 	Name: Maddy Hughes
		 	Title: Vice President

  
 [Signature Page to
Investments Supplemental Indenture No. 2]Exhibit 10.1

 

SECURITIES
PURCHASE AGREEMENT

 

This
SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of April 21, 2017 by and among Tianci International,
Inc., a Nevada corporation, (the “Company”), and the individual listed in Exhibit B hereto and affixes
its signature on the signature page of this Agreement (the “Purchaser”).

 

RECITALS

 

WHEREAS,
the Company and the Purchaser are executing and delivering this Agreement in accordance with and in reliance upon the exemption
from securities registration afforded by Section 4(2) of the Securities Act of 1933 (the “Securities Act”) and/or
Regulation S (“Regulation S”) as promulgated under the Securities Act;

 

WHEREAS,
the Company is offering certain shares of its common stock, par value $0.0001 per share, (the “Common Stock”) at price
of $0.01 per share to the Purchaser;

 

WHEREAS,
the Company is offering up to 500,000 shares of Common Stock to the Purchaser listed in Exhibit B, who severally but not jointly
enters into this Agreement and makes representations and warranties hereunder;

 

WHEREAS,
the Purchaser is a “non-US person” as defined in Regulation S, acquiring the Shares solely for its own account for
the purpose of investment;

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser hereby agree as follows:

 

     

     

    

 

ARTICLE
I

 

Purchase
and Sale of the Shares

 

Section
1.1Purchase Price and Closing.

 

(a)       Subject
to the terms and conditions hereof, the Company agrees to issue and sell to the Purchaser and, in consideration of and in express
reliance upon the representations, warranties, covenants, terms and conditions of this Agreement, the Purchaser agrees to purchase
for $0.01 per Share, such number of shares
of Common Stock (each a “Share” and collectively the “Shares”) for an aggregate price of listed
on the signature page hereto (the “Purchase Price”).

 

(b)       Subject
to all conditions to closing being satisfied or waived, the closing of the purchase and sale
of the Shares (the “Closing”) shall take place at the offices of Hunter Taubman Fischer & Li LLC, the Company’s
legal counsel, on the date of the occurrence of completion of and receipt by the Company of the Purchase Price (the “Closing
Date”). 

 

(c)       Subject
to the terms and conditions of this Agreement, at the Closing the Company shall deliver or cause
to be delivered to the Purchaser (i) a certificate for such number of Shares, and (ii) any other documents required to be delivered
pursuant to this Agreement. At the time of the Closing, the Purchaser shall have delivered its Purchase Price by wire transfer
pursuant to the wire information contained in this Agreement or by check. 

 

ARTICLE
II

 

Representations
and Warranties

 

Section
2.1Representations and Warranties of the Company and its Subsidiaries. The Company hereby represents and warrants to
the Purchaser on behalf of itself, its Subsidiaries (as hereinafter defined), as of the date hereof (except as set forth on the
Schedule of Exceptions attached hereto with each numbered Schedule corresponding to the section number herein), as follows:

 

(a)       Organization,
Good Standing and Power. The Company is a corporation or other entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of its jurisdiction of incorporation or organization (as applicable) and respectively, has
the requisite corporate power to own, lease and operate its properties and assets and to conduct its business as it is now being
conducted. Except as set forth on Schedule 2.1(a), the Company and each of its Subsidiaries is duly qualified to do business
and is in good standing in every jurisdiction in which the nature of the business conducted or property owned by it makes such
qualification necessary except for any jurisdiction(s) (alone or in the aggregate) in which the failure to be so qualified will
not have a Material Adverse Effect (as defined in Section 2.1(g) hereof).

 

    	 	2	 

     

    

 

(b)      Corporate
Power; Authority and Enforcement. The Company has the requisite corporate power and authority to enter into and perform its
obligations under this Agreement, and to issue and sell the Shares in accordance with the terms hereof. The execution,
delivery and performance of this Agreement by the Company and the consummation by it of the transactions contemplated hereby and
thereby have been duly and validly authorized by all necessary corporate action, and no further consent or authorization of the
Company or its Board of Directors or stockholders is required. This Agreement constitutes, or shall constitute when executed and
delivered, a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except
as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservator
ship, receiver ship or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies
or by other equitable principles of general application.

 

(c)      Capitalization.
The authorized capital stock of the Company and the shares thereof currently issued and outstanding as of March
16, 2017 is set forth in the Company’s Form 10-Q Periodic Report for the periods ended January 31, 2017 (the “Form
10-Q”) and, except as set forth in the on Schedule 2.1(c) hereto, is the
authorized and issued and outstanding capital stock of the Company as at the date hereof.

 

(i)
no shares of Common Stock are entitled to preemptive, conversion or other rights and there are no outstanding options, warrants,
scrip, rights to subscribe to, call or commitments of any character whatsoever relating to, or securities or rights convertible
into, any shares of capital stock of the Company;

 

(ii)
there are no contracts, commitments, understandings, or arrangements by which the Company is or may become bound to issue additional
shares of capital stock of the Company or options, securities or rights convertible into shares of capital stock of the Company;

 

(iii)
the Company is not a party to any agreement granting registration or anti-dilution rights to any person with respect to any of
its equity or debt securities;

 

(iv)
the Company is not a party to, and it has no knowledge of, any agreement restricting the voting or transfer of any shares of the
capital stock of the Company.

 

(v)
The offer and sale of all capital stock, convertible securities, rights, warrants, or options of the Company issued prior to the
Closing complied with all applicable Federal and state securities laws, except where non-compliance
would not have a Material Adverse Effect. The Company has furnished or made available to the Purchaser true and correct
copies of the Company’s Articles of Incorporation, as amended and in effect on the date hereof (the “Articles”),
and the Company’s Bylaws, as amended and in effect on the date hereof (the “Bylaws”). Except as restricted
under applicable federal, state, local or foreign laws and regulations, the Articles, this Agreement, or as set forth on Schedule
2.1 (c), no written or oral contract, instrument, agreement, commitment, obligation, plan or arrangement of the Company shall
limit the payment of dividends on the Company’s Preferred Shares, or its Common Stock.

 

(d)      Issuance
of Shares. The Shares to be issued at the Closing have been duly authorized by all necessary corporate action and the Preferred
Shares, when paid for or issued in accordance with the terms hereof, shall be validly issued and outstanding, fully paid and non-assessable.

 

(e)      Subsidiaries.
As of the date of this Agreement, the Company does not have any subsidiary.

 

    	 	3	 

     

    

 

(f)
     Commission Documents, Financial Statements. Except as set forth in Schedule 2.1 (f), the
Company has filed all reports, schedules, forms, statements and other documents required to be filed by it with the U.S. Securities
and Exchange Commission (the “Commission” or “SEC”) pursuant to the reporting requirements of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), including the Form 10-Q
and other material filed pursuant to Section 13(a) or 15(d) of the Exchange Act (all of the foregoing including filings
incorporated by reference therein being referred to herein as the “Commission Documents”). The Company has
not provided to the Purchaser any material non-public information or other information which, according to applicable law, rule
or regulation, was required to have been disclosed publicly by the Company but which has not been so disclosed, other than (i)
with respect to the transactions contemplated by this Agreement, or (ii) pursuant to a non-disclosure or confidentiality agreement
signed by the Purchaser. At the time of the respective filings, the Form 10-K’s and the Form 10-Q’s complied in all
material respects with the requirements of the Exchange Act and the rules and regulations of the Commission promulgated thereunder
and other federal, state and local laws, rules and regulations applicable to such documents. As of their respective filing dates,
none of the Form 10-K’s or Form 10-Q’s contained any untrue statement of a material fact; and none omitted to state
a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. The financial statements of the Company included in the Commission Documents comply
as to form in all material respects with applicable accounting requirements and the published rules and regulations of the Commission
or other applicable rules and regulations with respect thereto. Such financial statements have been prepared in accordance with
United States generally accepted accounting principles (“GAAP”) applied on a consistent basis during the periods
involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto or (ii) in the case of unaudited
interim statements, to the extent they may not include footnotes or may be condensed or summary statements), and fairly present
in all material respects the consolidated financial position of the Company as of the dates thereof and the results of operations
and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).

 

(g)     No
Material Adverse Effect. As of October 13, 2016 when a change of control occurred and as at the
date of this Agreement, the Company have not experienced or suffered any Material Adverse Effect. For the purposes of this Agreement,
“Material Adverse Effect” shall mean (i) any material adverse effect upon the assets, properties, financial condition,
business or prospects of the Company, and its Subsidiaries, when taken as a consolidated whole, and/or (ii) any condition, circumstance,
or situation that would prohibit or otherwise materially interfere with the ability of the Company to perform any of its material
covenants, agreements and obligations under this Agreement.

 

(h)     No
Undisclosed Liabilities. Other than as disclosed in the Company’s Commission Documents
or on Schedule 2.1(h) to the knowledge of the Company, neither the Company, nor the Subsidiaries has any liabilities, obligations,
claims or losses (whether liquidated or unliquidated, secured or unsecured, absolute, accrued, contingent or otherwise) other
than those incurred in the ordinary course of the Company’s and the Subsidiaries’ respective businesses and which,
individually or in the aggregate, do not or would not have a Material Adverse Effect.

 

    	 	4	 

     

    

 

(i)       No
Undisclosed Events or Circumstances. To the Company’s knowledge, no event or circumstance has occurred or exists with
respect to the Company, the Subsidiaries or their respective businesses, properties, operations or financial condition, which,
under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so
publicly announced or disclosed.

 

(j)       Title
to Assets. Except where non-compliance would not have a Material
Adverse Effect, each
of the Company and the Subsidiaries has good and
marketable title to (i) all properties and assets purportedly owned or used by them as reflected in the Financial Statements,
(ii) all properties and assets necessary for the conduct of their business as currently conducted, and (iii) all of the real and
personal property reflected in the Financial Statements free and clear of any Lien. All leases are valid and subsisting and in
full force and effect.

 

(k)      Actions
Pending. There is no action, suit, claim, investigation, arbitration, alternate dispute resolution proceeding or any other
proceeding pending or, to the knowledge of the Company, threatened against or involving the Company which
questions the validity of this Agreement or the transactions contemplated hereby or thereby or any action taken or to be taken
pursuant hereto or thereto. Except where the same would not have a Material Adverse Effect, there is no action, suit, claim, investigation,
arbitration, alternate dispute resolution proceeding or any other proceeding pending or, to the knowledge of the Company, threatened
against or involving the Company involving any of their respective properties or assets. To the knowledge of the Company, there
are no outstanding orders, judgments, injunctions, awards or decrees of any court, arbitrator or governmental or regulatory
body against the Company, the Subsidiaries or any of their respective executive officers or directors in their capacities as such.

 

(l)       Compliance
with Law. The Company and the Subsidiaries have all material franchises, permits, licenses, consents and other governmental
or regulatory authorizations and approvals necessary for the conduct of their respective business as now being conducted by it
unless the failure to possess such franchises, permits, licenses, consents and other governmental or regulatory authorizations
and approvals, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect.

 

(m)     No
Violation. The business of the Company and the Subsidiaries is not being conducted in violation of any Federal, state, local
or foreign governmental laws, or rules, regulations and ordinances of any of any governmental entity, except for possible violations
which singularly or in the aggregate could not reasonably be expected to have a Material Adverse Effect. The Company is not required
under Federal, state, local or foreign law, rule or regulation to obtain any consent, authorization or order of, or make any filing
or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under
this Agreement, or issue and sell the Shares in accordance with the terms hereof or thereof (other than (x) any consent, authorization
or order that has been obtained as of the date hereof, (y) any filing or registration that has been made as of the date hereof
or (z) any filings which may be required to be made by the Company with the Commission or state securities administrators subsequent
to the Closing.)

 

    	 	5	 

     

    

 

(n)      No
Conflicts. The execution, delivery and performance of this Agreement by the Company and the consummation by the Company of
the transactions contemplated herein and therein do not and will not (i) violate any provision of the Company’s Certificate
or Bylaws, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, mortgage,
deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Company is a party or by
which it or its properties or assets are bound, (iii) create or impose a lien, mortgage, security interest, pledge, charge or
encumbrance (collectively, “Lien”) of any nature on any property of the Company under any agreement or any
commitment to which the Company is a party or by which the Company is bound or by which any of its respective properties or assets
are bound, or (iv) result in a violation of any federal, state, local or foreign statute, rule, regulation, order, judgment or
decree (including Federal and state securities laws and regulations) applicable to the Company or any of its subsidiaries or by
which any property or asset of the Company or any of its subsidiaries are bound or affected, provided, however,
that, excluded from the foregoing in all cases are such conflicts, defaults, terminations, amendments, accelerations, cancellations
and violations as would not, individually or in the aggregate, have a Material Adverse Effect.

 

(o)      Certain
Fees. Except as set forth on Schedule 2.1(o) hereto, no brokers fees, finders fees
or financial advisory fees or commissions will be payable by the Company with respect to the transactions contemplated by this
Agreement.

 

(p)      Disclosure.
Except as set forth in Schedule 2.1(p), neither this Agreement nor the Schedules hereto nor any other documents, certificates
or instruments furnished to the Purchaser by or on behalf of the Company or the Subsidiaries in connection with the transactions
contemplated by this Agreement contain any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements made herein or therein, taken as a whole and in the light of the circumstances under which they were made
herein or therein, not false or misleading.

 

(q)      Intellectual
Property. Each of the Company and the Subsidiaries owns or has the lawful right to use all patents, trademarks, domain names
(whether or not registered) and any patentable improvements or copyrightable derivative works thereof, websites and intellectual
property rights relating thereto, service marks, trade names, copyrights, licenses and authorizations, and all rights with respect
to the foregoing, which are necessary for the conduct of their respective business as now conducted without any conflict with
the rights of others, except where the failure to so own or possess would not have a Material Adverse Effect.

 

(r)      Books
and Record Internal Accounting Controls. Except as may have otherwise been disclosed in the Form 10-Ks or the Form 10-Qs,
the books and records of the Company and the Subsidiaries accurately reflect in all material respects the information relating
to the business of the Company and the Subsidiaries, the location and collection of their assets, and the nature of all transactions
giving rise to the obligations or accounts receivable of the Company, or the Subsidiaries. Except as disclosed in
the Company’s Commission Documents or on Schedule 2.1(r), the Company and the Subsidiaries maintain a system of internal
accounting controls sufficient, in the judgment of the Company, to provide reasonable assurance that (i) transactions are executed
in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted
only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate actions are taken with respect to any differences.

 

    	 	6	 

     

    

 

(s)      Material
Agreements. Any and all written or oral contracts, instruments, agreements, commitments, obligations, plans or arrangements,
the Company and the Subsidiaries is a party to, that a copy of which would be required to be filed with the Commission as an exhibit
to a registration statement on Form S-1 (collectively, the “Material Agreements”) if the Company were registering
securities under the Securities Act has previously been publicly filed with the Commission in the Commission Documents. Each of
the Company and the Subsidiaries has in all material respects performed all the obligations required to be performed by them to
date under the foregoing agreements, have received no notice of default and are not in default under any Material Agreement now
in effect the result of which would cause a Material Adverse Effect.

 

(t)       Transactions
with Affiliates. Except as set forth in the Financial Statements or in the Commission Documents, there are no loans, leases,
agreements, contracts, royalty agreements, management contracts or arrangements or other continuing transactions between (a) the
Company on the one hand, and (b) on the other hand, any officer, employee, consultant or director of the Company or any person
owning any capital stock of the Company or any member of the immediate family of such officer, employee, consultant, director
or stockholder or any corporation or other entity controlled by such officer, employee, consultant, director or stockholder, or
a member of the immediate family of such officer, employee, consultant, director or stockholder.

 

Section
2.2Representations and Warranties of the Purchaser. Each Purchaser, severally but not jointly, hereby makes the following
representations and warranties to the Company as of the date hereof:

 

(a)      No
Conflicts. The execution, delivery and performance of this Agreement and the consummation by such Purchaser of the transactions
contemplated hereby and thereby or relating hereto do not and will not conflict with, or constitute a default (or an event which
with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of any agreement, indenture or instrument or obligation to which such Purchaser is a party or by which its properties
or assets are bound, or result in a violation of any law, rule, or regulation, or any order, judgment or decree of any court or
governmental agency applicable to such Purchaser or its properties (except for such conflicts, defaults and violations as would
not, individually or in the aggregate, have a material adverse effect on such Purchaser). Such Purchaser is not required to obtain
any consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for
it to execute, deliver or perform any of its obligations under this Agreement, provided, that for purposes of the representation
made in this sentence, such Purchaser is assuming and relying upon the accuracy of the relevant representations and agreements
of the Company herein.

 

(b)      Status
of Purchaser. The Purchaser is a “non-US person” as defined in Regulation S. The Purchaser further makes the representations
and warranties to the Company set forth on Exhibit A. Such Purchaser is not required to be registered as a broker-dealer
under Section 15 of the Exchange Act and such Purchaser is not a broker-dealer, nor an affiliate of a broker-dealer.

 

(c)       Reliance
on Exemptions. The Purchaser understands that the Shares are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying upon the
truth and accuracy of, and the Purchaser’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility
of the Purchaser to acquire the Shares.

 

    	 	7	 

     

    

 

(d)       Information.
The Purchaser and its advisors, if any, have had the opportunity to ask questions of management of the Company and its Subsidiaries
and have been furnished with all information relating to the business, finances and operations of the Company and information
relating to the offer and sale of the Shares which have been requested by the Purchaser or its advisors. Neither such inquiries
nor any other due diligence investigation conducted by the Purchaser or any of its advisors or representatives shall modify, amend
or affect the Purchaser’s right to rely on the representations and warranties of the Company contained herein. The Purchaser
understands that its investment in the Shares involves a significant degree of risk. The Purchaser further represents to the Company
that the Purchaser’s decision to enter into this Agreement has been based solely on the independent evaluation of the Purchaser
and its representatives.

 

(e)       Governmental
Review. The Purchaser understands that no United States federal or state agency or any other government or governmental agency
has passed upon or made any recommendation or endorsement of the Shares.

 

(f)     Transfer
or Re-sale. The Purchaser understands that the sale or re-sale of the Shares has not been and is not being registered under
the Securities Act or any applicable state securities laws, and the Shares may not be transferred unless (i) the Shares are sold
pursuant to an effective registration statement under the Securities Act, (ii) the Purchaser shall have delivered to the Company
an opinion of counsel that shall be in form, substance and scope customary for opinions of counsel in comparable transactions
to the effect that the Shares to be sold or transferred may be sold or transferred pursuant to an exemption from such registration,
which opinion shall be reasonably acceptable to the Company, (iii) the Shares are sold or transferred to an “affiliate”
(as defined in Rule 144 promulgated under the Securities Act (or a successor rule) (“Rule 144”)) of the Purchaser
who agrees to sell or otherwise transfer the Shares only in accordance with this Section 2.2(f) and who is a non-US person, (iv)
the Shares are sold pursuant to Rule 144, or (v) the Shares are sold pursuant to Regulation S under the Securities Act (or a successor
rule) (“Regulation S”). Notwithstanding the foregoing or anything else contained herein to the contrary, the
Shares may be pledged as collateral in connection with a bona fide margin account or other lending arrangement.

 

(g)       Legends.
The Purchaser understands that the Shares shall bear a restrictive legend in the form as set forth under Section 5.1 of this Agreement.
The Purchaser understands that, until such time the Shares may be sold pursuant to Rule 144 or Regulation S without any restriction
as to the number of securities as of a particular date that can then be immediately sold, the Shares may bear a restrictive legend
in substantially the form set forth under Section 5.1 (and a stop-transfer order may be placed against transfer of the certificates
evidencing such Securities).

 

(h)       Residency.
The Purchaser is a resident of the jurisdiction set forth immediately below such Purchaser’s name on the signature pages
hereto.

 

(i)        No
General Solicitation. The Purchaser acknowledges that the Shares were not offered to such Purchaser by means of any form of
general or public solicitation or general advertising, or publicly disseminated advertisements or sales literature, including
(i) any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media, or broadcast
over television or radio, or (ii) any seminar or meeting to which such Purchaser was invited by any of the foregoing means of
communications.

 

    	 	8	 

     

    

 

(j)       Rule
144. Such Purchaser understands that the Shares must be held indefinitely unless such Shares are registered under the Securities
Act or an exemption from registration is available. Such Purchaser acknowledges that such Purchaser is familiar with Rule 144
and Rule 144A, of the rules and regulations of the Commission, as amended, promulgated pursuant to the Securities Act (“Rule
144”), and that such person has been advised that Rule 144 and Rule 144A, as applicable, permits resales only under
certain circumstances. Such Purchaser understands that to the extent that Rule 144 or Rule 144A is not available, such Purchaser
will be unable to sell any Shares without either registration under the Securities Act or the existence of another exemption from
such registration requirement.

 

(j)       Brokers.
Purchaser does not have any knowledge of any brokerage or finder’s fees or commissions that are or will be payable by the
Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other person or entity
with respect to the transactions contemplated by this Agreement.

 

(k)      Acquisition
for Investment. The Purchaser is a “non-US person” as defined in Regulation S, acquiring the Shares solely
for the its own account for the purpose of investment and not with a view to or for sale in
connection with a distribution to anyone.

ARTICLE III

 

Covenants

 

The
Company covenants with the Purchaser as follows, which covenants are for the benefit of the Purchaser and its permitted assignees
(as defined herein).

 

Section
3.1Securities Compliance. The Company shall notify the Commission in accordance with its rules and regulations, of
the transactions contemplated by any of this Agreement, and shall take all other necessary action and proceedings as may be required
and permitted by applicable law, rule and regulation, for the legal and valid issuance of the Shares to the Purchaser or subsequent
holders.

 

Section
3.2Confidential Information. The Purchaser agrees that such Purchaser and its employees, agents and representatives
will keep confidential and will not disclose, divulge or use (other than for purposes of monitoring its investment in the Company)
any confidential information which such Purchaser may obtain from the Company pursuant to financial statements, reports and other
materials submitted by the Company to such Purchaser pursuant to this Agreement, unless such information is known to the public
through no fault of such Purchaser or his or its employees or representatives; provided, however, that a Purchaser may disclose
such information (i) to its attorneys, accountants and other professionals in connection with their representation of such Purchaser
in connection with such Purchaser’s investment in the Company, (ii) to any prospective permitted transferee of the Shares,
so long as the prospective transferee agrees to be bound by the provisions of this Section 3.3, or (iii) to any general partner
or affiliate of such Purchaser.

 

    	 	9	 

     

    

 

Section
3.3Compliance with Laws. The Company shall comply to comply in all material respects, with all applicable laws, rules,
regulations and orders, except where non-compliance could not reasonably be expected to have a Material
Adverse Effect.

 

Section
3.4Keeping of Records and Books of Account. The Company shall keep adequate records and books of account, in which
complete entries will be made in accordance with GAAP consistently applied, reflecting all financial transactions of the Company,
and in which, for each fiscal year, all proper reserves for depreciation, depletion, obsolescence, amortization, taxes, bad debts
and other purposes in connection with its business shall be made.

 

Section
3.5Disclosure of Material Information. The Company covenants and agrees that neither it nor any other person acting
on its or their behalf has provided or, from and after the filing of the Press Release, will provide any Purchaser or its agents
or counsel with any information that the Company believes constitutes material non-public information (other than with respect
to the transactions contemplated by this Agreement), unless prior thereto such Purchaser shall have executed a specific written
agreement regarding the confidentiality and use of such information. The Company understands and confirms that the Purchaser shall
be relying on the foregoing covenants in effecting transactions in securities of the Company. At the time of the filing of the
Press Release, no Purchaser shall be in possession of any material, nonpublic information received from the Company, any of its
subsidiaries or any of its respective officers, directors, employees or agents, that is not disclosed in the Press Release. The
Company shall not disclose the identity of any Purchaser in any filing with the SEC except as required by the rules and regulations
of the SEC thereunder. In the event of a breach of the foregoing covenant by the Company, , or any of its or their respective
officers, directors, employees and agents, in addition to any other remedy provided herein, a Purchaser may notify the Company,
and the Company shall make public disclosure of such material nonpublic information within two (2) trading days of such notification.

 

Section
3.6No Manipulation of Price. The Company will not take, directly or indirectly, any action designed to cause or result
in, or that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any
securities of the Company.

 

ARTICLE
IV

 

CONDITIONS

 

Section
4.1Conditions Precedent to the Obligation of the Company to Sell the Shares. The obligation hereunder of the Company
to issue and sell the Shares is subject to the satisfaction or waiver, at or before the Closing, of each of the conditions set
forth below. These conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole
discretion.

 

(a)     Accuracy
of the Purchaser’s Representations and Warranties. The representations and warranties of the Purchaser in this Agreement
shall be true and correct in all material respects as of the date when made and as of the Closing Date as though made at that
time, except for representations and warranties that are expressly made as of a particular date, which shall be true and correct
in all material respects as of such date.

 

    	 	10	 

     

    

 

(b)      Performance
by the Purchaser. The Purchaser shall have performed, satisfied and complied in all respects with all covenants, agreements
and conditions required by this Agreement to be performed, satisfied or complied with by such Purchaser at or prior to the Closing.

 

(c)      No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any
of the transactions contemplated by this Agreement.

 

(d)      Delivery
of Purchase Price. The Purchase Price for the Shares shall have been delivered to the Company.

 

(e)      Delivery
of this Agreement. This Agreement shall have been duly executed and delivered by the Purchaser to the Company.

 

Section
4.2Conditions Precedent to the Obligation of the Purchaser to Purchase the Shares. The obligation hereunder of the
Purchaser to acquire and pay for the Shares offered in Offering is subject to the satisfaction or waiver, at or before the Closing,
of each of the conditions set forth below. These conditions are for the Purchaser’s sole benefit and may be waived by such
Purchaser at any time in its sole discretion.

 

(a)       Accuracy
of the Company’s Representations and Warranties. Each of the representations and warranties of the Company in this Agreement
shall be true and correct in all respects as of the date when made and as of the Closing Date as though made at that time, except
for representations and warranties that are expressly made as of a particular date, which shall be true and correct in all respects
as of such date.

 

(b)       Performance
by the Company. The Company shall have performed, satisfied and complied in all respects with all covenants, agreements and
conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing.

 

(c)       No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any
of the transactions contemplated by this Agreement.

 

(d)       No
Proceedings or Litigation. No action, suit or proceeding before any arbitrator or any governmental authority shall have been
commenced, and no investigation by any governmental authority shall have been threatened, against the Company, or any of the officers,
directors or affiliates of the Company seeking to restrain, prevent or change the transactions contemplated by this Agreement,
or seeking damages in connection with such transactions.

 

(e)       
Certificates. The Company shall have executed and delivered to the Purchaser the certificates (in such denominations as
such Purchaser shall request) for the Shares being acquired by such Purchaser immediately after the Closing (in such denominations
as such Purchaser shall request) to such address set forth next to the Purchaser with respect to the Closing.

 

    	 	11	 

     

    

 

(f)       Resolutions.
The Board of Directors of the Company shall have adopted resolution consistent with Section 2.1(b) hereof in a form reasonably
acceptable to such Purchaser (the “Resolution”).

 

(g)       Material
Adverse Effect. No Material Adverse Effect shall have occurred at or before the Closing Date.

 

ARTICLE
V

 

Stock
Certificate Legend

 

Section
5.1Legend. Each certificate representing the Shares shall be stamped or otherwise imprinted
with a legend substantially in the following form (in addition to any legend required by applicable state securities or
“blue sky” laws):

 

THESE
SECURITIES REPRESENTED BY THIS CERTIFICATE (THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”). THE SECURITIES WERE ISSUED IN A TRANSACTION EXEMPT FROM THE REGISTRATION
REDISTRICTIREMENTS OF THE SECURITIES ACT PURSUANT TO REGULATION S PROMULGATED UNDER IT. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED
OR OTHERWISE DISPOSED OF IN THE UNITED STATES UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES
LAWS OR THE COMPANY SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT IS
NOT REDISTRICTIRED. FURTHER, HEDGING TRANSACTIONS WITH REGARD TO THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH
THE SECURITIES ACT.

 

ARTICLE
VI

 

Indemnification

 

Section
6.1General Indemnity. The Company agrees to indemnify and hold harmless the Purchaser (and their respective directors,
officers, managers, partners, members, shareholders, affiliates, agents, successors and assigns) from and against any and all
losses, liabilities, deficiencies, costs, damages and expenses (including, without limitation, reasonable attorneys’ fees,
charges and disbursements) incurred by the Purchaser as a result of any inaccuracy in or breach of the representations, warranties
or covenants made by the Company herein. The Purchaser, severally but not jointly, agrees to indemnify and hold harmless the Company
and its directors, officers, affiliates, agents, successors and assigns from and against any and all losses, liabilities, deficiencies,
costs, damages and expenses (including, without limitation, reasonable attorneys’ fees, charges and disbursements) incurred
by the Company as a result of any inaccuracy in or breach of the representations, warranties or covenants made by such Purchaser
herein. The maximum aggregate liability of the Purchaser pursuant to its indemnification obligations under this Article VI shall
not exceed the portion of the Purchase Price paid by the Purchaser hereunder. In no event shall any “Indemnified Party”
(as defined below) be entitled to recover consequential or punitive damages resulting from a breach or violation of this Agreement.

 

    	 	12	 

     

    

 

Section
6.2Indemnification Procedure. Any party entitled to indemnification under this Article VI (an “Indemnified
Party”) will give written notice to the indemnifying party of any matters giving rise to a claim for indemnification;
provided, that the failure of any party entitled to indemnification hereunder to give notice as provided herein shall not
relieve the indemnifying party of its obligations under this Article VI except to the extent that the indemnifying party is actually
prejudiced by such failure to give notice. In case any action, proceeding or claim is brought against an Indemnified Party in
respect of which indemnification is sought hereunder, the indemnifying party shall be entitled to participate in and, unless in
the reasonable judgment of the Indemnified Party a conflict of interest between it and the indemnifying party may exist with respect
of such action, proceeding or claim, to assume the defense thereof with counsel reasonably satisfactory to the Indemnified Party.
In the event that the indemnifying party advises an Indemnified Party that it will contest such a claim for indemnification hereunder,
or fails, within thirty (30) days of receipt of any indemnification notice to notify, in writing, such person of its election
to defend, settle or compromise, at its sole cost and expense, any action, proceeding or claim (or discontinues its defense at
any time after it commences such defense), then the Indemnified Party may, at its option, defend, settle or otherwise compromise
or pay such action or claim. In any event, unless and until the indemnifying party elects in writing to assume and does so assume
the defense of any such claim, proceeding or action, the Indemnified Party’s costs and expenses arising out of the defense,
settlement or compromise of any such action, claim or proceeding shall be losses subject to indemnification hereunder. The Indemnified
Party shall cooperate fully with the indemnifying party in connection with any negotiation or defense of any such action or claim
by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Indemnified
Party which relates to such action or claim. The indemnifying party shall keep the Indemnified Party fully apprised at all times
as to the status of the defense or any settlement negotiations with respect thereto. If the indemnifying party elects to defend
any such action or claim, then the Indemnified Party shall be entitled to participate in such defense with counsel of its choice
at its sole cost and expense. The indemnifying party shall not be liable for any settlement of any action, claim or proceeding
effected without its prior written consent, provided, however, that the indemnifying party shall be liable for any
settlement if the indemnifying party is advised of the settlement but fails to respond to the settlement within thirty (30) days
of receipt of such notification. Notwithstanding anything in this Article VI to the contrary, the indemnifying party shall not,
without the Indemnified Party’s prior written consent, settle or compromise any claim or consent to entry of any judgment
in respect thereof which imposes any future obligation on the Indemnified Party or which does not include, as an unconditional
term thereof, the giving by the claimant or the plaintiff to the Indemnified Party of a release from all liability in respect
of such claim. The indemnification required by this Article VI shall be made by periodic payments of the amount thereof during
the course of investigation or defense, as and when bills are received or expense, loss, damage or liability is incurred, so long
as the Indemnified Party irrevocably agrees to refund such moneys if it is ultimately determined by a court of competent jurisdiction
that such party was not entitled to indemnification. The indemnity agreements contained herein shall be in addition to (a) any
cause of action or similar rights of the Indemnified Party against the indemnifying party or others, and (b) any liabilities the
indemnifying party may be subject to pursuant to the law.

 

    	 	13	 

     

    

 

ARTICLE
VII

 

Miscellaneous

 

Section
7.1Fees and Expenses. Except as otherwise set forth in this Agreement, each party shall pay the fees and expenses of
its advisors, counsel, accountants and other experts, if any, and all other expenses, incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement.

 

Section
7.2Specific Enforcement, Consent to Jurisdiction.

 

(a)      The
Company and the Purchaser acknowledge and agree that irreparable damage would occur in the event that any of the provisions of
this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed
that the parties shall be entitled to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement
and to enforce specifically the terms and provisions hereof or thereof, this being in addition to any other remedy to which any
of them may be entitled by law or equity.

 

(b)       Each
of the Company and the Purchaser (i) hereby irrevocably submits to the jurisdiction of the United States District Court sitting
in the Southern District of New York and the courts of the State of New York located in New York county for the purposes of any
suit, action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby or thereby and
(ii) hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of
the suit, action or proceeding is improper. Each of the Company and the Purchaser consents to process being served in any such
suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of
delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing in this Section 7.2 shall affect or limit any right to serve
process in any other manner permitted by law. Each party hereby irrevocably waives personal service of process and consents to
process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices
to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.
The Company hereby appoints Hunter Taubman Fischer & Li LLC, with offices at 1450 Broadway, 26th Floor, New York,
NY 10018 as its agent for service of process in New York. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner permitted by law.

 

Section
7.3      Entire Agreement; Amendment. This Agreement contains the entire understanding and agreement of the parties with
respect to the matters covered hereby and, except as specifically set forth herein, neither the Company nor any of the Purchaser
makes any representations, warranty, covenant or undertaking with respect to such matters and they supersede all prior understandings
and agreements with respect to said subject matter, all of which are merged herein. No provision of this Agreement may be waived
or amended other than by a written instrument signed by the Company and the Purchaser, and no provision hereof may be waived other
than by a written instrument signed by the party against whom enforcement of any such waiver is sought.

 

    	 	14	 

     

    

 

Section
7.4      Notices. All notices, demands, consents, requests, instructions and other communications to be given or delivered
or permitted under or by reason of the provisions of this Agreement or in connection with the transactions contemplated hereby
shall be in writing and shall be deemed to be delivered and received by the intended recipient as follows: (i) if personally delivered,
on the business day of such delivery (as evidenced by the receipt of the personal delivery service), (ii) if mailed certified
or registered mail return receipt requested, two (2) business days after being mailed, (iii) if delivered by overnight courier
(with all charges having been prepaid), on the business day of such delivery (as evidenced by the receipt of the overnight courier
service of recognized standing), or (iv) if delivered by facsimile transmission, on the business day of such delivery if sent
by 6:00 p.m. in the time zone of the recipient, or if sent after that time, on the next succeeding business day (as evidenced
by the printed confirmation of delivery generated by the sending party’s telecopier machine). If any notice, demand, consent,
request, instruction or other communication cannot be delivered because of a changed address of which no notice was given (in
accordance with this Section 7.4), or the refusal to accept same, the notice, demand, consent, request, instruction or other communication
shall be deemed received on the second business day the notice is sent (as evidenced by a sworn affidavit of the sender). All
such notices, demands, consents, requests, instructions and other communications will be sent to the following addresses or facsimile
numbers as applicable:

 

If
to the Company:

 

Tianci
International, Inc.

 

Xusheng
Building, Yintian Road,

Bo’an
District, Shenzhen, Guangdong Province,

People’s
Republic of China

 

with
copies (which shall not constitute notice) to:

 

Hunter
Taubman Fischer & Li LLC

1450
Broadway, 26th Floor

New
York, NY 10018

 

If
to Purchaser:

 

The
address listed on Exhibit B

 

Any
party hereto may from time to time change its address for notices by giving at least ten (10) days written notice of such changed
address to the other party hereto.

 

Section
7.5Waivers. No waiver by any party of any default with respect to any provision, condition or requirement of this Agreement
shall be deemed to be a continuing waiver in the future or a waiver of any other provisions, condition or requirement hereof,
nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right
accruing to it thereafter.

 

    	 	15	 

     

    

 

Section
7.6Headings. The section headings contained in this Agreement (including, without limitation, section headings and
headings in the exhibits and schedules) are inserted for reference purposes only and shall not affect in any way the meaning,
construction or interpretation of this Agreement. Any reference to the masculine, feminine, or neuter gender shall be a reference
to such other gender as is appropriate. References to the singular shall include the plural and vice versa.

 

Section
7.7Successors and Assigns. This Agreement may not be assigned by a party hereto without the prior written consent of
the Company or the Purchaser, as applicable, provided, however, that, subject to federal and state securities laws,
a Purchaser may assign its rights and delegate its duties hereunder in whole or in part to an affiliate or to a third party acquiring
all or substantially all of its Shares in a private transaction without the prior written consent of the Company or the other
Purchaser, after notice duly given by such Purchaser to the Company provided, that no such assignment or obligation shall
affect the obligations of such Purchaser hereunder and that such assignee agrees in writing to be bound, with respect to the transferred
securities, by the provisions hereof that apply to the Purchaser. The provisions of this Agreement shall inure to the benefit
of and be binding upon the respective permitted successors and assigns of the parties. Nothing in this Agreement, express or implied,
is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies,
obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

Section
7.8Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State
of New York, without giving effect to any of the conflicts of law principles which would result in the application of the substantive
law of another jurisdiction. This Agreement shall not be interpreted or construed with any presumption against the party causing
this Agreement to be drafted.

 

Section
7.9Survival. The representations and warranties of the Company and the Purchaser shall survive the execution and delivery
hereof and the Closing hereunder for a period of three (3) years following the Closing Date.

 

Section
7.10Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed shall
be deemed to be an original and, all of which taken together shall constitute one and the same Agreement and shall become effective
when counterparts have been signed by each party and delivered to the other parties hereto, it being understood that all parties
need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, such signature shall
create a valid binding obligation of the party executing (or on whose behalf such signature is executed) the same with the same
force and effect as if such facsimile signature were the original thereof.

 

Section
7.11Severability. The provisions of this Agreement are severable and, in the event that any court of competent jurisdiction
shall determine that any one or more of the provisions or part of the provisions contained in this Agreement shall, for any reason,
be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect
any other provision or part of a provision of this Agreement and such provision shall be reformed and construed as if such invalid
or illegal or unenforceable provision, or part of such provision, had never been contained herein, so that such provisions would
be valid, legal and enforceable to the maximum extent possible.

 

Section
7.12Individual Capacity. The Purchaser enters into this Agreement on its own capacity and makes representations and
warranties contained under this Agreement.

 

Section
7.13Termination. This Agreement may be terminated prior to Closing by mutual written agreement of the Purchaser and
the Company.

 

Section
7.14. Language. The Agreement is in both English and Chinese, which both have binding effects. If there is any conflict
between the English and Chinese language, English language prevails.

 

[Remainder
of Page Intentionally Left Blank; Signature Pages Follow]

 

    	 	16	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officer as of
the date first above written.

 

	The
    Company: 	TIANCI INTERNATIONAL, INC. 
	 	 	 
	 	By:	/s/
    Cuilian     Cai
	 	 	Name:
    Cuilian Cai
	 	 	Title:
    Chief Executive Officer

 

[Signature
Page of the Company]

 

    	 	17	 

     

    

 

Signature
Page of the Purchaser

 

 

IN
WITNESS WHEREOF, the Purchaser has caused this Agreement to be duly executed individually or by its authorized officer or member
as of the date first above written.

 

The
Purchaser: 

 

	By:	/s/
    Shifang Wan	 
	Name:	Shifang
    Wan	 

 

Number
of Shares Purchased: 500,000

Total
Purchase Price: $5,000

 

Address
and Contacts of Purchaser 

 

Unit
16B, Xusheng Building,

Yintian
Road, Bao'an District, Shenzhen, 

Guangdong
Province, China

 

Telephone:
+86 (0564)38416483

Email:
1034992963@qq.com

 

    	 	18	 

     

    

 

EXHIBIT
A TO

THE
SECURITIES PURCHASE AGREEMENT

 

NON
U.S. PERSON REPRESENTATIONS

 

 

The
Purchaser indicating that it is not a U.S. person, severally and not jointly, further represents and warrants to the Company as
follows:

 

		1.	At
                                         the time of (a) the offer by the Company and (b) the acceptance of the offer by such
                                         person or entity, of the Shares, such person or entity was outside the United States.

 

		2.	Such
                                         person or entity is acquiring the Shares for such Shareholder’s own account, for
                                         investment and not for distribution or resale to others and is not purchasing the Shares
                                         for the account or benefit of any U.S. person, or with a view towards distribution to
                                         any U.S. person, in violation of the registration requirements of the Securities Act.

 

		3.	Such
                                         person or entity will make all subsequent offers and sales of the Shares either (x) outside
                                         of the United States in compliance with Regulation S; (y) pursuant to a registration
                                         under the Securities Act; or (z) pursuant to an available exemption from registration
                                         under the Securities Act. Specifically, such person or entity will not resell the Shares
                                         to any U.S. person or within the United States prior to the expiration of a period commencing
                                         on the Closing Date and ending on the date that is one year thereafter (the “Distribution
                                         Compliance Period”), except pursuant to registration under the Securities Act
                                         or an exemption from registration under the Securities Act.

 

		4.	Such
                                         person or entity has no present plan or intention to sell the Shares in the United States
                                         or to a U.S. person at any predetermined time, has made no predetermined arrangements
                                         to sell the Shares and is not acting as a Distributor of such securities.

 

		5.	Neither
                                         such person or entity, its Affiliates nor any Person acting on behalf of such person
                                         or entity, has entered into, has the intention of entering into, or will enter into any
                                         put option, short position or other similar instrument or position in the U.S. with respect
                                         to the Shares at any time after the Closing Date through the Distribution Compliance
                                         Period except in compliance with the Securities Act.

 

		6.	Such
                                         person or entity consents to the placement of a legend on any certificate or other document
                                         evidencing the Shares substantially in the form set forth in Section 5.1.

 

		7.	Such
                                         person or entity is not acquiring the Shares in a transaction (or an element of a series
                                         of transactions) that is part of any plan or scheme to evade the registration provisions
                                         of the Securities Act.

 

		8.	Such
                                         person or entity has sufficient knowledge and experience in finance, securities, investments
                                         and other business matters to be able to protect such person’s or entity’s
                                         interests in connection with the transactions contemplated by this Agreement.

 

    	 	19	 

     

    

 

		9.	Such
                                         person or entity has consulted, to the extent that it has deemed necessary, with its
                                         tax, legal, accounting and financial advisors concerning its investment in the Shares.

 

		10.	Such
                                         person or entity understands the various risks of an investment in the Shares and can
                                         afford to bear such risks for an indefinite period of time, including, without limitation,
                                         the risk of losing its entire investment in the Shares.

 

		11.	Such
                                         person or entity has had access to the Company’s publicly filed reports with the
                                         SEC and has been furnished during the course of the transactions contemplated by this
                                         Agreement with all other public information regarding the Company that such person or
                                         entity has requested and all such public information is sufficient for such person or
                                         entity to evaluate the risks of investing in the Shares.

 

		12.	Such
                                         person or entity has been afforded the opportunity to ask questions of and receive answers
                                         concerning the Company and the terms and conditions of the issuance of the Shares.

 

		13.	Such
                                         person or entity is not relying on any representations and warranties concerning the
                                         Company made by the Company or any officer, employee or agent of the Company, other than
                                         those contained in this Agreement.

 

		14.	Such
                                         person or entity will not sell or otherwise transfer the Shares unless either (A) the
                                         transfer of such securities is registered under the Securities Act or (B) an exemption
                                         from registration of such securities is available.

 

		15.	Such
                                         person or entity represents that the address furnished on its signature page to this
                                         Agreement is the principal residence if he is an individual or its principal business
                                         address if it is a corporation or other entity.

 

		16.	Such
                                         person or entity understands and acknowledges that the Shares have not been recommended
                                         by any federal or state securities commission or regulatory authority, that the foregoing
                                         authorities have not confirmed the accuracy or determined the adequacy of any information
                                         concerning the Company that has been supplied to such person or entity and that any representation
                                         to the contrary is a criminal offense.

 

    	 	20	 

     

    

 

Exhibit
B

 

List
of Purchasers

 

	No.	Shares	Name	Address
    (in China)
	1	500,000	 

        Shifang
        Wan
	 

        Unit
        16B, Xusheng Building,Yintian Road, Bao'an District, Shenzhen, Guangdong Province, China

	 	Total:
    500,000	 

 

    	 	21	 

     

    

 

Schedules

to
Securities Purchase Agreement

 

Schedule
2.1(a). Organization, Good Standing and Power

Not
applicable.

 

Schedule
2.1(c). Capitalization

Not
applicable.

 

Schedule
2.1(f). Commission Documents, Financial Statements

None.

 

Schedule
2.1(h). No Undisclosed Liabilities

None.

 

Schedule
2.1(o). Certain Fees

None.

 

Schedule
2.1(p). Disclosure

None.

 

Schedule
2.1(r). Books and Record Internal Accounting Controls

None.

 

 22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]